emat

Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples

 

 

► Subscribe to EMAT database

 

Sectors covered by our analysts

 

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

 

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

 

Transaction Multiples for the Valuation of Private Companies

Recordati / Eusa Pharma (UK)

No EMAT : 109851
Announced Date : 03/12/2021
Type : Exit ,Acquisition of Majority Stake
Deal Value : Yes
Acquirer : Recordati

Target : Eusa Pharma (UK)
Country : England
Sector of activity :
  • Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Biomedical Research Laboratory
Business Description :
Founded in March 2015, EUSA Pharma is a pharmaceutical company with a portfolio of 4 rare and niche oncology products. > Products include: Qarziba®, an anti-GD2 monoclonal antibody indicated for...

Transaction multiples available
EV/
Sales
EV/
Gross Profit
EV/
EBITDA
EV/
EBIT
Eq/
PBT
P/E Price
to Book
Specific
multiple(s)
Historic
Current
Rating : **
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Biomedical Research Laboratory » = 31
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
30/04/2021 Private Group led by EW Healthcare Partners Laboratoires Majorelle Paris * 109837
18/06/2021 Ethypharm Altan Pharma Ireland *** 109827

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report